/4-((5-(3-(4-(pyridin-2-yl)cyclopentyl)-1h-pyrazol-3-yl)amino)-benzenesulfonamide Derivatives And Similar Compounds As Cdk Inhibitors For The Treatment Of Cancer
Abstract
Disclosed herein are compounds used as inhibitors of cyclin-dependent kinases. Disclosed herein is the use of these inhibitors for inhibiting cyclin-dependent kinases, and the use of such compounds for treating cancer.
Full Text
What is claimed is:
Disclosed herein are compounds used as inhibitors of cyclin-dependent kinases. Disclosed herein is the use of these inhibitors for inhibiting cyclin-dependent kinases, and the use of such compounds for treating cancer.
Timeline
Filed
03/13/2026Published
07/16/2026Granted
Not AvailableIPC Codes(21)
C07D 403/08:linked by a carbon chain containing alicyclic rings
A61K 31/4155:not condensed and containing further heterocyclic rings
A61K 31/4178:not condensed and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin